The autism gene problem

I wonder why we are still asking questions like "How do you find genes for a disorder that eludes definition?"1 You even suggest the solution when you quote Steve Scherer saying that "while...neurolignin could be a candidate in some rare cases, other researchers have countered that the family where the gene was found may have mental retardation rather than autism." The answer is to look at candidate genes and find out what symptoms are phenotypically unique to people who have a particular varian

Written byThomas Caruso
| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share

I wonder why we are still asking questions like "How do you find genes for a disorder that eludes definition?"1 You even suggest the solution when you quote Steve Scherer saying that "while...neurolignin could be a candidate in some rare cases, other researchers have countered that the family where the gene was found may have mental retardation rather than autism." The answer is to look at candidate genes and find out what symptoms are phenotypically unique to people who have a particular variant of the gene compared with people who don't have that variant.

With the availability of genotyping technology we can now look at groups of people who have, maybe an even more difficult disease to diagnose, schizophrenia, and categorize them into groups based on their genotypes. Then we can look at those groups and, from the similarities of phenotype within the group, and the unique differences from other ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies